# A Bibliometric Analysis of HPV-Positive Oropharyngeal Squamous Cell Carcinoma from 2000 to 2023

**Authors:** Yingying Cui, Wei Li, Binbin Li

PMC · DOI: 10.3390/pathogens14030289 · Pathogens · 2025-03-15

## TL;DR

This study maps research trends in HPV-positive oropharyngeal cancer from 2000 to 2023, identifying key contributors, topics, and growth in the field.

## Contribution

A comprehensive bibliometric analysis of HPV-positive OPSCC research, revealing trends and emerging themes over 23 years.

## Key findings

- Research on HPV-positive OPSCC has steadily increased since 2000.
- Key topics include survival, radiotherapy, and p16 as top keywords.
- The USA, Johns Hopkins University, and the journal Head and Neck are major contributors.

## Abstract

Human-papillomavirus-positive oropharyngeal squamous cell carcinoma (HPV-positive OPSCC) is a distinct disease characterized by unique clinical and molecular features compared to HPV-negative OPSCC. A comprehensive bibliometric analysis of HPV-positive OPSCC research was conducted in this study to identify key trends, research hotspots, and emerging frontiers in the field. Data were retrieved from the Web of Science Core Collection database. The distributions of contributors, including countries, institutions, authors, journals, and cooperative networks related to HPV-positive OPSCC, were analyzed and visualized using VOSviewer 1.6.20, CiteSpace 6.3.R1, and the R package Bibliometrix 4.0.0. In addition, the most influential publications and high-frequency keywords were identified and analyzed to discern key topics in this field. A total of 3895 articles and reviews on HPV-positive OPSCC were identified, involving 106 countries, 620 journals, and 18949 authors. The main contributors include the USA (1908 publications), Johns Hopkins University (310 publications), the journal Head and Neck (320 publications), and Erich M. Sturgis (94 publications). The top three keywords are “survival”, “radiotherapy”, and “p16”. There has been a steadily increasing research interest in HPV-positive OPSCC over the last 23 years. Current studies focus on diagnosis, treatment strategies, prognosis, recurrence, and disease surveillance. This bibliometric analysis highlights key contributors and emerging themes, offering insights for future research directions.

## Linked entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029]

## Full-text entities

- **Genes:** CDKN2A (cyclin dependent kinase inhibitor 2A) [NCBI Gene 1029] {aka ARF, CAI2, CDK4I, CDKN2, CMM2, INK4}
- **Diseases:** Positive (MESH:D000377), Oropharyngeal Squamous Cell Carcinoma (MESH:D000077195)
- **Species:** Human papillomavirus (species) [taxon 10566]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11945886/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11945886/full.md

## References

73 references — full list in the complete paper: https://tomesphere.com/paper/PMC11945886/full.md

---
Source: https://tomesphere.com/paper/PMC11945886